TapewireFind a company

person · Reporting owner

Nally Michael

Disclosed activity across 3 companies

Tapewire entity
11792
SEC CIK
0001763945

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Generate Biomedicines, Inc.GENB · Entity 1553Director · Chief Executive OfficerMarch 04, 2026March 06, 2026
Merck & Co., Inc.MRK · Entity 2807EVP, Chief Marketing OfficerFebruary 26, 2021March 02, 2021
PPG INDUSTRIES INCPPG · Entity 3193DirectorSeptember 11, 2026September 14, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Generate Biomedicines, Inc.

Report date March 04, 2026 · Filed March 06, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect572,707 Reported balance After 2026-03-04 transaction · row 1
1 source row

Row 1 · 2026-03-04 · Purchase · Acquired 20,000 · Balance 572,707

Common StockSEC Table I · non-derivativeIndirectBy MTN 2024 GST Trust1,316,654 Reported balance Holding disclosure · report date 2026-03-04 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 1,316,654

F1: The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that he is a beneficial owner of such shares for the purpose of Section 16 of the Exchange Act, or for any other purpose.

Common StockSEC Table I · non-derivativeIndirectBy MTN 2024 GRAT999,793 Reported balance Holding disclosure · report date 2026-03-04 · row 3 Holding and transaction disclosures are not merged.
1 source row

Row 3 · Balance 999,793

F1: The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that he is a beneficial owner of such shares for the purpose of Section 16 of the Exchange Act, or for any other purpose.

Filing footnotes · ownership attribution and instrument terms

F1: The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that he is a beneficial owner of such shares for the purpose of Section 16 of the Exchange Act, or for any other purpose.

Merck & Co., Inc.

Report date February 26, 2021 · Filed March 02, 2021

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect19,630.091 Reported balance After 2021-02-26 transaction · row 1 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 1 · 2021-02-26 · Grant · Acquired 7,127 · Balance 19,630.091

F1: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/29/18. Performance shares were paid out at 166 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2020.

F2: Holdings include shares acquired in dividend reinvestment transactions.

Common Stock - 401(k) PlanSEC Table I · non-derivativeIndirectBy 401(k)1,759.8185 Reported balance Holding disclosure · report date 2021-02-26 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 1,759.8185

F3: Includes shares acquired and dividends earned through January 8, 2021 in the Merck U.S. Savings Plan, a 401(k) plan.

Filing footnotes · ownership attribution and instrument terms

F1: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/29/18. Performance shares were paid out at 166 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2020.

F2: Holdings include shares acquired in dividend reinvestment transactions.

F3: Includes shares acquired and dividends earned through January 8, 2021 in the Merck U.S. Savings Plan, a 401(k) plan.

PPG INDUSTRIES INC

Report date September 11, 2026 · Filed September 14, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Phantom Stock UnitsSEC Table II · derivative / convertible securityDirect10,436.9316 Reported balance After 2026-09-11 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2026-09-11 · Grant · Acquired 98.0881 · Balance 10,436.9316

F1: The security converts to common stock on a one-for-one basis.

F2: After termination of service as a Director of PPG Industries, Inc.

F3: Total of all phantom stock units held by the reporting person in the PPG Industries, Inc. Deferred Compensation Plan for Directors. Phantom stock units represent interests in an unfunded unitized company stock fund comprised of stock and cash. The number of shares attributed to the reporting person as a Plan participant may change from time to time without the volition of the reporting person depending on the fair market value of the issuer's common stock and the amount of cash in the fund.

Filing footnotes · ownership attribution and instrument terms

F1: The security converts to common stock on a one-for-one basis.

F2: After termination of service as a Director of PPG Industries, Inc.

F3: Total of all phantom stock units held by the reporting person in the PPG Industries, Inc. Deferred Compensation Plan for Directors. Phantom stock units represent interests in an unfunded unitized company stock fund comprised of stock and cash. The number of shares attributed to the reporting person as a Plan participant may change from time to time without the volition of the reporting person depending on the fair market value of the issuer's common stock and the amount of cash in the fund.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
September 10, 2021 Filed Sep 14, 2021 18:18 UTC PPG INDUSTRIES INC PPG · Entity 3193 GrantPhantom Stock Units · Derivative 3.6621 $153.03 $560.41
Disclosure

SEC source: 0001209191-21-055847 · doc4.xml · derivative · entry 1

Nally Michael · CIK 0001763945 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6.5426

Underlying: Common Stock · 3.6621 shares

Expires not disclosed

F1 · derivative.exercise_price: The security converts to common stock on a one-for-one basis.

F2 · derivative.exercise_date: After termination of service as a Director of PPG Industries, Inc.

F2 · derivative.expiration_date: After termination of service as a Director of PPG Industries, Inc.

F3 · balance_after: Total of all phantom stock units held by the reporting person in the PPG Industries, Inc. Deferred Compensation Plan for Directors.

Read SEC document
June 11, 2021 Filed Jun 15, 2021 21:54 UTC PPG INDUSTRIES INC PPG · Entity 3193 GrantPhantom Stock Units · Derivative 2.8805 $177.53 $511.38
Disclosure

SEC source: 0001209191-21-040696 · doc4.xml · derivative · entry 1

Nally Michael · CIK 0001763945 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2.8805

Underlying: Common Stock · 2.8805 shares

Expires not disclosed

F1 · derivative.exercise_price: The security converts to common stock on a one-for-one basis.

F2 · derivative.exercise_date: After termination of service as a Director of PPG Industries, Inc.

F2 · derivative.expiration_date: After termination of service as a Director of PPG Industries, Inc.

F3 · balance_after: Total of all phantom stock units held by the reporting person in the PPG Industries, Inc. Deferred Compensation Plan for Directors.

Read SEC document
April 15, 2021 Filed Apr 19, 2021 19:09 UTC PPG INDUSTRIES INC PPG · Entity 3193 GrantRestricted Stock Units · Derivative 947 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-027239 · doc4.xml · derivative · entry 1

Nally Michael · CIK 0001763945 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 947

Underlying: Common Stock · 947 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of PPG Common Stock.

F2 · derivative.exercise_date: The restricted stock units vest on April 20, 2022.

F2 · derivative.expiration_date: The restricted stock units vest on April 20, 2022.

Read SEC document
April 14, 2021 Filed Apr 17, 2021 00:05 UTC PPG INDUSTRIES INC PPG · Entity 3193 Exercise / conversionRestricted Stock Units · Derivative 164 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-027076 · doc4.xml · derivative · entry 2

Nally Michael · CIK 0001763945 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 164 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Upon the vesting of restricted stock units on April 14, 2021, which were granted to the reporting person on March 26, 2021, the reporting person is reporting the acquisition of 164 shares of common stock.

F1 · derivative.exercise_date: Upon the vesting of restricted stock units on April 14, 2021, which were granted to the reporting person on March 26, 2021, the reporting person is reporting the acquisition of 164 shares of common stock.

F1 · derivative.expiration_date: Upon the vesting of restricted stock units on April 14, 2021, which were granted to the reporting person on March 26, 2021, the reporting person is reporting the acquisition of 164 shares of common stock.

Read SEC document
April 14, 2021 Filed Apr 17, 2021 00:05 UTC PPG INDUSTRIES INC PPG · Entity 3193 Exercise / conversionCommon Stock 164 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-027076 · doc4.xml · nonDerivative · entry 1

Nally Michael · CIK 0001763945 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 264

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Upon the vesting of restricted stock units on April 14, 2021, which were granted to the reporting person on March 26, 2021, the reporting person is reporting the acquisition of 164 shares of common stock.

Read SEC document
March 26, 2021 Filed Mar 30, 2021 15:50 UTC PPG INDUSTRIES INC PPG · Entity 3193 GrantRestricted Stock Units · Derivative 164 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-023540 · doc4.xml · derivative · entry 1

Nally Michael · CIK 0001763945 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 164

Underlying: Common Stock · 164 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of PPG Common Stock.

F2 · derivative.exercise_date: The restricted stock units vest on April 14, 2021.

F2 · derivative.expiration_date: The restricted stock units vest on April 14, 2021.

Read SEC document
February 26, 2021 Filed Mar 2, 2021 16:39 UTC Merck & Co., Inc. MRK · Entity 2807 GrantCommon Stock 7,127 $72.62 $517,562.74
Disclosure

SEC source: 0001127602-21-008567 · form4.xml · nonDerivative · entry 1

Nally Michael · CIK 0001763945 · EVP, Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,630.091

F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/29/18. Performance shares were paid out at 166 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2020.

F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
October 30, 2020 Filed Nov 3, 2020 21:48 UTC Merck & Co., Inc. MRK · Entity 2807 Exercise / conversionRestricted Stock Unit · Derivative 2,287 $0.00 $0.00
Disclosure

SEC source: 0001127602-20-028034 · form4.xml · derivative · entry 4

Nally Michael · CIK 0001763945 · EVP, Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,288

Underlying: Common Stock · 2,287 shares

Expires 2021-10-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

F4 · derivative.exercise_date: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 10/30/2019, 10/30/2020 and 10/30/2021.

Read SEC document
October 30, 2020 Filed Nov 3, 2020 21:48 UTC Merck & Co., Inc. MRK · Entity 2807 Tax withholdingCommon Stock 995 $75.89 $75,510.55
Disclosure

SEC source: 0001127602-20-028034 · form4.xml · nonDerivative · entry 2

Nally Michael · CIK 0001763945 · EVP, Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,407.936

F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
October 30, 2020 Filed Nov 3, 2020 21:48 UTC Merck & Co., Inc. MRK · Entity 2807 Exercise / conversionCommon Stock 2,287 $75.89 $173,560.43
Disclosure

SEC source: 0001127602-20-028034 · form4.xml · nonDerivative · entry 1

Nally Michael · CIK 0001763945 · EVP, Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,402.936

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 05, 2020 Filed May 6, 2020 21:14 UTC Merck & Co., Inc. MRK · Entity 2807 Exercise / conversionRestricted Stock Unit · Derivative 2,345 $0.00 $0.00
Disclosure

SEC source: 0001127602-20-015653 · form4.xml · derivative · entry 7

Nally Michael · CIK 0001763945 · EVP, Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,345 shares

Expires 2020-05-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

Read SEC document
May 05, 2020 Filed May 6, 2020 21:14 UTC Merck & Co., Inc. MRK · Entity 2807 Tax withholdingCommon Stock 1,020 $76.86 $78,397.20
Disclosure

SEC source: 0001127602-20-015653 · form4.xml · nonDerivative · entry 4

Nally Michael · CIK 0001763945 · EVP, Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,033.935

F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
May 05, 2020 Filed May 6, 2020 21:14 UTC Merck & Co., Inc. MRK · Entity 2807 Exercise / conversionCommon Stock 2,345 $76.86 $180,236.70
Disclosure

SEC source: 0001127602-20-015653 · form4.xml · nonDerivative · entry 3

Nally Michael · CIK 0001763945 · EVP, Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,053.935

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 04, 2020 Filed May 6, 2020 21:14 UTC Merck & Co., Inc. MRK · Entity 2807 Exercise / conversionRestricted Stock Unit · Derivative 1,298 $0.00 $0.00
Disclosure

SEC source: 0001127602-20-015653 · form4.xml · derivative · entry 6

Nally Michael · CIK 0001763945 · EVP, Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,300

Underlying: Common Stock · 1,298 shares

Expires 2021-05-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

F4 · derivative.exercise_date: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2019, 5/4/2020 and 5/4/2021.

Read SEC document
May 04, 2020 Filed May 6, 2020 21:14 UTC Merck & Co., Inc. MRK · Entity 2807 Tax withholdingCommon Stock 565 $77.67 $43,883.55
Disclosure

SEC source: 0001127602-20-015653 · form4.xml · nonDerivative · entry 2

Nally Michael · CIK 0001763945 · EVP, Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,708.935

Read SEC document
May 04, 2020 Filed May 6, 2020 21:14 UTC Merck & Co., Inc. MRK · Entity 2807 Exercise / conversionCommon Stock 1,298 $77.67 $100,815.66
Disclosure

SEC source: 0001127602-20-015653 · form4.xml · nonDerivative · entry 1

Nally Michael · CIK 0001763945 · EVP, Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,273.935

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 01, 2020 Filed May 5, 2020 20:51 UTC Merck & Co., Inc. MRK · Entity 2807 GrantStock Option (Right to Buy) · Derivative 57,391 $0.00 Strike: $77.67 $0.00
Disclosure

SEC source: 0001127602-20-015454 · form4.xml · derivative · entry 3

Nally Michael · CIK 0001763945 · EVP, Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,391

Underlying: Common Stock · 57,391 shares

Expires 2030-04-30

F3 · derivative.exercise_date: The option vests and becomes exercisable in three equal installments on 5/1/2021, 5/1/2022 and 5/1/2023.

Read SEC document
February 28, 2020 Filed Mar 3, 2020 22:35 UTC Merck & Co., Inc. MRK · Entity 2807 GrantCommon Stock 3,328 $76.56 $254,791.68
Disclosure

SEC source: 0001127602-20-009156 · form4.xml · nonDerivative · entry 1

Nally Michael · CIK 0001763945 · EVP, Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,908.399

F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/31/17. Performance shares were paid out at 137 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2019.

F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
October 30, 2019 Filed Nov 1, 2019 21:07 UTC Merck & Co., Inc. MRK · Entity 2807 Exercise / conversionRestricted Stock Unit · Derivative 2,287 $85.10 $194,623.70
Disclosure

SEC source: 0001225208-19-014015 · doc4.xml · derivative · entry 4

Nally Michael · CIK 0001763945 · EVP, Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,575

Underlying: Common Stock · 2,287 shares

Expires 2021-10-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

F4 · derivative.exercise_date: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 10/30/2019, 10/30/2020 and 10/30/2021.

Read SEC document
October 30, 2019 Filed Nov 1, 2019 21:07 UTC Merck & Co., Inc. MRK · Entity 2807 Tax withholdingCommon Stock 652 $85.10 $55,485.20
Disclosure

SEC source: 0001225208-19-014015 · doc4.xml · nonDerivative · entry 2

Nally Michael · CIK 0001763945 · EVP, Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,543.71

F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
October 30, 2019 Filed Nov 1, 2019 21:07 UTC Merck & Co., Inc. MRK · Entity 2807 Exercise / conversionCommon Stock 2,287 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-014015 · doc4.xml · nonDerivative · entry 1

Nally Michael · CIK 0001763945 · EVP, Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,195.71

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 10, 2019 Filed May 13, 2019 21:06 UTC Merck & Co., Inc. MRK · Entity 2807 Exercise / conversionRestricted Stock Unit · Derivative 1,811 $78.33 $141,855.63
Disclosure

SEC source: 0001104659-19-028977 · a4.xml · derivative · entry 4

Nally Michael · CIK 0001763945 · EVP, Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,811 shares

Expires 2019-05-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

Read SEC document
May 10, 2019 Filed May 13, 2019 21:06 UTC Merck & Co., Inc. MRK · Entity 2807 Tax withholdingCommon Stock 516 $78.33 $40,418.28
Disclosure

SEC source: 0001104659-19-028977 · a4.xml · nonDerivative · entry 2

Nally Michael · CIK 0001763945 · EVP, Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,860.065

F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
May 10, 2019 Filed May 13, 2019 21:06 UTC Merck & Co., Inc. MRK · Entity 2807 Exercise / conversionCommon Stock 1,811 $0.00 $0.00
Disclosure

SEC source: 0001104659-19-028977 · a4.xml · nonDerivative · entry 1

Nally Michael · CIK 0001763945 · EVP, Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,376.065

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 04, 2019 Filed May 7, 2019 23:40 UTC Merck & Co., Inc. MRK · Entity 2807 Exercise / conversionRestricted Stock Unit · Derivative 1,298 $80.00 $103,840.00
Disclosure

SEC source: 0001104659-19-027584 · a4.xml · derivative · entry 5

Nally Michael · CIK 0001763945 · EVP, Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,598

Underlying: Common Stock · 1,298 shares

Expires 2021-05-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

F5 · derivative.exercise_date: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2019, 5/4/2020 and 5/4/2021.

Read SEC document
May 04, 2019 Filed May 7, 2019 23:40 UTC Merck & Co., Inc. MRK · Entity 2807 Tax withholdingCommon Stock 370 $80.00 $29,600.00
Disclosure

SEC source: 0001104659-19-027584 · a4.xml · nonDerivative · entry 2

Nally Michael · CIK 0001763945 · EVP, Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,565.065

F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
May 04, 2019 Filed May 7, 2019 23:40 UTC Merck & Co., Inc. MRK · Entity 2807 Exercise / conversionCommon Stock 1,298 $0.00 $0.00
Disclosure

SEC source: 0001104659-19-027584 · a4.xml · nonDerivative · entry 1

Nally Michael · CIK 0001763945 · EVP, Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,935.065

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 03, 2019 Filed May 7, 2019 23:40 UTC Merck & Co., Inc. MRK · Entity 2807 GrantStock Option (right to buy) · Derivative 45,163 $0.00 Strike: $80.00 $0.00
Disclosure

SEC source: 0001104659-19-027584 · a4.xml · derivative · entry 4

Nally Michael · CIK 0001763945 · EVP, Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,163

Underlying: Common Stock · 45,163 shares

Expires 2029-05-02

F3 · derivative.exercise_date: The option vests and becomes exercisable in three equal installments on 5/3/2020, 5/3/2021 and 5/3/2022.

Read SEC document
February 25, 2019 Filed Feb 27, 2019 23:55 UTC Merck & Co., Inc. MRK · Entity 2807 GrantCommon Stock 1,527 $80.38 $122,740.26
Disclosure

SEC source: 0001225208-19-003896 · doc4.xml · nonDerivative · entry 1

Nally Michael · CIK 0001763945 · EVP, Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,527

F1 · shares: Distrubtion of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/31/16. Performance shares were paid out at 126 percent of target awards. Includes dividends accured over the three-year performance period ending December 31, 2018.

F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
April 20, 2000 Filed Apr 22, 2022 17:34 UTC PPG INDUSTRIES INC PPG · Entity 3193 Exercise / conversionPhantom Stock Units · Derivative 947 $131.70 $124,719.90
Disclosure

SEC source: 0001209191-22-025290 · doc4.xml · derivative · entry 2

Nally Michael · CIK 0001763945 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 961.7102

Underlying: Common Stock · 947 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The security converts to common stock on a one-for-one basis.

F3 · derivative.exercise_date: After termination of service as a Director of PPG Industries, Inc.

F3 · derivative.expiration_date: After termination of service as a Director of PPG Industries, Inc.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.